Publicaciones en las que colabora con Sergio Portal Núñez (9)

2019

  1. Molecular evidence of field cancerization initiated by diabetes in colon cancer patients

    Molecular Oncology, Vol. 13, Núm. 4, pp. 857-872

2018

  1. Activation of bombesin receptor Subtype-3 by [D-Tyr 6 ,β-Ala 11 ,Phe 13 ,Nle 14 ]bombesin 6-14 increased glucose uptake and lipogenesis in human and rat adipocytes

    Molecular and Cellular Endocrinology, Vol. 474, pp. 10-19

2017

  1. 2017 update on the relationship between diabetes and colorectal cancer: Epidemiology, potential molecular mechanisms and therapeutic implications

    Oncotarget, Vol. 8, Núm. 11, pp. 18456-18485

  2. Colon cancer modulation by a diabetic environment: A single institutional experience

    PLoS ONE, Vol. 12, Núm. 3

2015

  1. SecreEffect of bombesin receptor subtype-3 and its synthetic agonist on signaling, glucose transport and metabolism in myocytes from patients with obesity and type 2 diabetes

    International Journal of Molecular Medicine, Vol. 35, Núm. 4, pp. 925-931

2014

  1. Human BRS-3 receptor: Functions/role in cell signaling pathways and glucose metabolism in obese or diabetic myocytes

    Peptides, Vol. 51, pp. 91-99

2013

  1. Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes

    Molecular and Cellular Endocrinology, Vol. 367, Núm. 1-2, pp. 109-115

2010

  1. Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor

    Journal of Cellular Physiology, Vol. 225, Núm. 2, pp. 585-592

2008

  1. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor

    Journal of Pharmacology and Experimental Therapeutics, Vol. 324, Núm. 2, pp. 463-474